Relapsing De Novo Membranous Nephropathy
Allograft membranous glomerulopathy can be a recurrent or de novo disease. Both instead have different underlying immune pathophysiology and disease pattern. While the introduction of ANTI-PLAR2 and THS7A brought new insights into the management of Immune/primary MN, the treatment of de novo MN is n...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Transplantation |
| Online Access: | http://dx.doi.org/10.1155/2022/6754520 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554940496609280 |
|---|---|
| author | Ala Ali Huda Al-Taee Thaer J. Kadhim |
| author_facet | Ala Ali Huda Al-Taee Thaer J. Kadhim |
| author_sort | Ala Ali |
| collection | DOAJ |
| description | Allograft membranous glomerulopathy can be a recurrent or de novo disease. Both instead have different underlying immune pathophysiology and disease pattern. While the introduction of ANTI-PLAR2 and THS7A brought new insights into the management of Immune/primary MN, the treatment of de novo MN is not clear. Relapsing de novo MN in a kidney transplant was rarely reported. Here, we present a case of relapsing de novo MN without evidence of rejection and a gratifying response to rituximab. |
| format | Article |
| id | doaj-art-83e4999ea2ea4bed95949d884d491f09 |
| institution | Kabale University |
| issn | 2090-6951 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Transplantation |
| spelling | doaj-art-83e4999ea2ea4bed95949d884d491f092025-02-03T05:50:04ZengWileyCase Reports in Transplantation2090-69512022-01-01202210.1155/2022/6754520Relapsing De Novo Membranous NephropathyAla Ali0Huda Al-Taee1Thaer J. Kadhim2Nephrology and Renal Transplantation CentreNephrology and Renal Transplantation CentreDepartment of PathologyAllograft membranous glomerulopathy can be a recurrent or de novo disease. Both instead have different underlying immune pathophysiology and disease pattern. While the introduction of ANTI-PLAR2 and THS7A brought new insights into the management of Immune/primary MN, the treatment of de novo MN is not clear. Relapsing de novo MN in a kidney transplant was rarely reported. Here, we present a case of relapsing de novo MN without evidence of rejection and a gratifying response to rituximab.http://dx.doi.org/10.1155/2022/6754520 |
| spellingShingle | Ala Ali Huda Al-Taee Thaer J. Kadhim Relapsing De Novo Membranous Nephropathy Case Reports in Transplantation |
| title | Relapsing De Novo Membranous Nephropathy |
| title_full | Relapsing De Novo Membranous Nephropathy |
| title_fullStr | Relapsing De Novo Membranous Nephropathy |
| title_full_unstemmed | Relapsing De Novo Membranous Nephropathy |
| title_short | Relapsing De Novo Membranous Nephropathy |
| title_sort | relapsing de novo membranous nephropathy |
| url | http://dx.doi.org/10.1155/2022/6754520 |
| work_keys_str_mv | AT alaali relapsingdenovomembranousnephropathy AT hudaaltaee relapsingdenovomembranousnephropathy AT thaerjkadhim relapsingdenovomembranousnephropathy |